Search results
Results from the WOW.Com Content Network
Former Cigna insurance executive says he quit after witnessing an industry that ‘puts profits over patients’ Ani Freedman Updated December 23, 2024 at 8:39 AM
A Zepbound injection pen. Eli Lilly’s weight loss drug Zepbound is no longer in short supply, the FDA said, worrying patients who use cheaper, off-brand versions of the drug.
Cigna Group said on Thursday its pharmacy benefit management unit had launched a program aiming to cap annual cost increases for health insurance providers and employers from new weight-loss drugs ...
[table-of-contents] stripped. In early November, the Food and Drug Administration (FDA) approved Zepbound, a weight loss drug to help with chronic weight management in adults who have obesity or ...
Under the new pricing plan, a month’s supply of the lowest dose, 2.5 milligrams, will cost $399, while a month’s supply of the 5 mg dose will cost $549.
The FDA's approval is based on data from two trials involving 469 participants, in which Zepbound helped ease breathing difficulties in patients with moderate to severe obstructive sleep apnea.
Eli Lilly announced it is cutting prices of its blockbuster weight-loss drug Zepbound after less than a year on the market.The company is pricing its 2.5mg doses at $399 per month and 5mg doses at ...
With insurance coverage, Zepbound can cost as low as $25 per month, but without coverage, the medication can cost more than $1,000 per month. Consumers who purchase Zepbound through LillyDirect ...